Somerset Pharmaceuticals, Inc. v. Shalala

This document cites

• Federal Cases - Norwich Eaton Pharmaceuticals, Inc. v. Bowen
• Federal Cases - Asarco, Inc. v. U.S. E.P.A.
• Federal Cases - S & R Corp. v. Jiffy Lube Intern., Inc.
• Federal Cases - Rybachek v. U.S. E.P.A.
• Federal Cases - United States v. Rutherford



See all quotations

• Federal Cases - Citizens To Preserve Overton Park, Inc v. Volpe
• Federal Cases - Twiggs v. U.S. Small Business Administration, 75-2450
• Federal Cases - Camp v. Pitts 8212 864
• Federal Cases - Federal Power Commission v. Florida Power Light Company 8212 38
• Federal Cases - Tenneco Oil Co. v. Dept. of Energy
• Federal Cases - Schering Corp. v. Food and Drug Admin.
• Federal Cases - Higgins v. Kelley, 77-1314
• US - Reference Stubs - Determination of reasons for voluntary withdrawal of a listed drug
• US - Reference Stubs - Scope of review
• US - Reference Stubs - Requirements for submission of bioavailability and bioequivalence data
• US - Reference Stubs - Registration of producers of drugs or devices
• US - Reference Stubs - New drugs
• US - Reference Stubs - Types of evidence to measure bioavailability or establish bioequivalence
• US - Reference Stubs - Removal of a drug product from the list
• US - Reference Stubs - Action to compel an officer of the United States to perform his duty
• US - Reference Stubs - Criteria for waiver of evidence of in vivo bioavailability or bioequivalence
• US - Reference Stubs - Federal question